• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria

tetano

Editor, Senior Moderator
Cell Rep


. 2024 Jul 24;43(8):114533.
doi: 10.1016/j.celrep.2024.114533. Online ahead of print. Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria

Kesego Tapela[SUP] 1 [/SUP], Diana Ahu Prah[SUP] 2 [/SUP], Becky Tetteh[SUP] 1 [/SUP], Franklin Nuokpem[SUP] 1 [/SUP], Daniel Dosoo[SUP] 2 [/SUP], Amin Coker[SUP] 3 [/SUP], Frederick Kumi-Ansah[SUP] 4 [/SUP], Emmanuella Amoako[SUP] 5 [/SUP], Kissi Ohene Assah[SUP] 6 [/SUP], Charlyne Kilba[SUP] 7 [/SUP], Nancy Nyakoe[SUP] 1 [/SUP], Darius Quansah[SUP] 8 [/SUP], Sylvester Languon[SUP] 2 [/SUP], Claudia Adzo Anyigba[SUP] 1 [/SUP], Felix Ansah[SUP] 1 [/SUP], Seth Agyeman[SUP] 9 [/SUP], Irene Amoakoh Owusu[SUP] 2 [/SUP], Kristan Schneider[SUP] 10 [/SUP], William K Ampofo[SUP] 6 [/SUP], Joe Kimanthi Mutungi[SUP] 2 [/SUP], Gloria Amegatcher[SUP] 11 [/SUP], Yaw Aniweh[SUP] 12 [/SUP], Gordon A Awandare[SUP] 1 [/SUP], Peter K Quashie[SUP] 13 [/SUP], Yaw Bediako[SUP] 14 [/SUP]



Affiliations
Free article Abstract

Ghana and other parts of West Africa have experienced lower COVID-19 mortality rates than other regions. This phenomenon has been hypothesized to be associated with previous exposure to infections such as malaria. This study investigated the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the influence of previous malaria exposure. Blood samples were collected from individuals with asymptomatic or symptomatic COVID-19 (n = 217). A variety of assays were used to characterize the SARS-CoV-2-specific immune response, and malaria exposure was quantified using Plasmodium falciparum ELISA. The study found evidence of attenuated immune responses to COVID-19 among asymptomatic individuals, with elevated proportions of non-classical monocytes and greater memory B cell activation. Symptomatic patients displayed higher P. falciparum-specific T cell recall immune responses, whereas asymptomatic individuals demonstrated elevated P. falciparum antibody levels. Summarily, this study suggests that P. falciparum exposure-associated immune modulation may contribute to reduced severity of SARS-CoV-2 infection among people living in malaria-endemic regions.

Keywords: COVID-19 West Africa; CP: Immunology; CP: Microbiology; Ghana; P. falciparum; SARS-CoV-2; SARS-CoV-2 severity; asymptomatic; immune response; immunomodulation; malaria/COVID-19 interplay; symptomatic.

 
Back
Top Bottom